Skip to main navigation Skip to search Skip to main content

Real-World Effectiveness and Safety of Mepolizumab in Severe Eosinophilic Asthma: Insights From the Korean Severe Asthma Registry (KoSAR)

Research output: Contribution to journal › Journal article › peer-review

Original languageKorean
JournalAllergy, Asthma & Immunology Research
StatePublished - 2025.05.1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this